Opioid-sparing effects of SoluMatrix indomethacin in a phase 3 study in patients with acute postoperative pain
The Clinical Journal of Pain Jan 22, 2018
Gharibo CG, et al. - The authors aimed at reporting the opioid-sparing effects of SoluMatrix indomethacin, developed using SoluMatrix Fine Particle Technology, in a phase 3 study in patients with acute pain following bunionectomy. Findings revealed that SoluMatrix indomethacin has a correlation with opioid-sparing effects in these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
